在重症患者中对美罗的生理学基础的药理动力学/药理动力学建模
Yujie Yang1, Yirong Wang1, Wei Zeng2
1Department of Pharmacy, The Third People's Hospital of Chengdu, College of Medicine, Southwest Jiaotong University, Chengdu, China.
Scientific reports
|August 20, 2024
概括
这项研究开发了一种基于生理学的药理动力学/药理动力学 (PBPK/PD) 模型,用于重症患者的美罗. 该PBPK/PD模型准确地预测了美罗胺的处置,指导了优化剂量策略,以改善患者的治疗结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药理动力学 药理动力学
- 药理动力学是什么 药理动力学
背景情况:
- 在重症患者中优化美罗胺剂量是具有挑战性的,因为改变了生理学.
- 基于生理学的药理动力学/药理动力学 (PBPK/PD) 建模为个性化剂量提供了一个有希望的方法.
研究的目的:
- 开发和验证PBPK/PD模型用于重症患者的美罗.
- 评估模型在预测美罗胺药理动力学和药理动力学方面的准确性.
- 为了在这个患者群体中提供对美罗胺剂量调整的参考.
主要方法:
- 在PK-Sim中建立了PBPK模型,并推断到重症患者.
- 使用HPLC-MS/MS分析对ICU患者样本的模型进行验证.
- 集成的PBPK与PK/PD模型 (f%T>MIC) 并使用蒙特卡洛模拟实现目标 (PTA) 的概率.
主要成果:
- 该PBPK模型准确地预测了重症患者的美罗胺处置 (MFE和GMFE在1.25倍的误差范围内).
- 治疗药物监测 (TDM) 显示,模拟和观察到的美罗胺水平之间的一致性为77.17%.
- 蒙特卡洛模拟表明,延长输液和频繁的管理对于实现治疗目标至关重要.
结论:
- 开发的PBPK/PD模型准确地预测了重症患者中美罗的药理动力学.
- 该模型支持优化的美罗胺剂量策略,包括延长输注,以提高疗效.
- 这种方法为治疗药物监测和重症监护机构的剂量调整提供了宝贵的指导.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Pharmacokinetic Models: Overview
627
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
627
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64
Model Approaches for Pharmacokinetic Data: Physiological Models
36
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
36
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
34
Physiological Pharmacokinetic Models: Assumption with Protein Binding
36
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
36


